These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10515821)

  • 1. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.
    Kaymakoglu S; Eraksoy H; Okten A; Demir K; Calangu S; Cakaloglu Y; Boztas G; Besisik F
    Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):71-6. PubMed ID: 9031903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis.
    Runyon BA; Akriviadis EA; Sattler FR; Cohen J
    Dig Dis Sci; 1991 Dec; 36(12):1782-6. PubMed ID: 1748049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Ljubicic N; Spajic D; Vrkljan MM; Altabas V; Doko M; Zovak M; Gacina P; Mihatov S
    Hepatogastroenterology; 2000; 47(35):1360-3. PubMed ID: 11100352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
    Rimola A; Salmerón JM; Clemente G; Rodrigo L; Obrador A; Miranda ML; Guarner C; Planas R; Solá R; Vargas V
    Hepatology; 1995 Mar; 21(3):674-9. PubMed ID: 7875666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
    Yakar T; Güçlü M; Serin E; Alişkan H; Husamettin E
    Dig Dis Sci; 2010 Apr; 55(4):1149-54. PubMed ID: 19424797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.
    Rimola A; Navasa M; Arroyo V
    Diagn Microbiol Infect Dis; 1995; 22(1-2):141-5. PubMed ID: 7587029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.
    Badawy AA; Zaher TI; Sharaf SM; Emara MH; Shaheen NE; Aly TF
    World J Gastroenterol; 2013 Feb; 19(8):1271-7. PubMed ID: 23483064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
    Reuken PA; Pletz MW; Baier M; Pfister W; Stallmach A; Bruns T
    Aliment Pharmacol Ther; 2012 May; 35(10):1199-208. PubMed ID: 22449290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ceftizoxime in acute peritonitis.
    Lou MA; Chen DF; Bansal M; Balasubramaniam S; Thadepalli H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():183-9. PubMed ID: 6296004
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.
    Angeloni S; Leboffe C; Parente A; Venditti M; Giordano A; Merli M; Riggio O
    World J Gastroenterol; 2008 May; 14(17):2757-62. PubMed ID: 18461661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
    Ariza J; Xiol X; Esteve M; Fernández Bañeres F; Liñares J; Alonso T; Gudiol F
    Hepatology; 1991 Jul; 14(1):91-8. PubMed ID: 2066075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis.
    Seguin P; Verdier MC; Chanavaz C; Engrand C; Laviolle B; Donnio PY; Mallédant Y
    J Antimicrob Chemother; 2009 Mar; 63(3):564-7. PubMed ID: 19168542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous bacterial peritonitis: clinical study, microbiological findings and clinical course.
    Aller R; de Luis DA; Boixeda D; Arocena C; Martín de Argila C; Moreira V
    Rev Esp Enferm Dig; 1997 Mar; 89(3):174-85. PubMed ID: 9141899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis.
    Castellote J; Xiol X; Verdaguer R; Ribes J; Guardiola J; Gimenez A; Casais L
    Am J Gastroenterol; 1990 Dec; 85(12):1605-8. PubMed ID: 2252025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
    Navasa M; Follo A; Llovet JM; Clemente G; Vargas V; Rimola A; Marco F; Guarner C; Forné M; Planas R; Bañares R; Castells L; Jimenez De Anta MT; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1011-7. PubMed ID: 8831596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, laboratory and bacterial profile of Spontaneous Bacterial Peritonitis in Chronic Liver Disease patients.
    Bibi S; Ahmed W; Arif A; Khan F; Alam SE
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):95-9. PubMed ID: 25703750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of ascites nitric oxide according to the treatment course in cirrhotic patients with spontaneous bacterial peritonitis].
    Park YS; Chon CY; Kim H; Paik YH; Song SY; Ahn SH; Hong S; Han KH; Moon YM
    Korean J Hepatol; 2004 Sep; 10(3):207-15. PubMed ID: 15385715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center.
    Na HY; Kim JH; Choe WH; Kwon SY; Yoo BC
    Korean J Gastroenterol; 2017 Feb; 69(2):129-134. PubMed ID: 28239081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.